Clinical trial
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Tunodafil Hydrochloride Tablets in Patients With Erectile Dysfunction
NCT07692867 is registered in ClinicalTrials.gov with Yangtze River Pharmaceutical Group Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Tunodafil Hydrochloride Tablets in Patients With Erectile Dysfunction
- Lead sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- January 25, 2022
- Enrollment
- 780 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.